Immix Biopharma, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $-404.7K | $-404.7K | — | — |
| FY2021 | $-1.6M | $-1.6M | $802 | $219.0K |
| FY2022 | $-7.4M | $-7.4M | — | $624.1K |
| FY2023 | $-11.4M | $-11.4M | $52.1K | $2.6M |
| FY2024 | $-14.6M | $-15.8M | $1.2M | $3.0M |
| FY2025 | $-23.9M | $-24.7M | $732.9K | $2.4M |